Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Exosome Treatment in Androgenetic Alopecia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating exosome therapy for androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exosome therapy (exosome)

Snippet

Sponsor: Yeditepe University Hospital | Conditions: Androgenetic Alopecia, Exosomes | Phase 3 | Status: COMPLETED